In the on-treatment analysis, only 1.2% of those randomly assigned to tirzepatide at any of the subcutaneous 5, 10, or 15 mg ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Bonnie Chapman, who has PCOS, revealed that she's been taking a weight loss drug to help her achieve her 'goal weight.' ...

Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...

produces maximal weight loss in patients with obesity compared with other surgical procedures and with weight loss drugs, ...

GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...

Total semaglutide sales rose to a whopping $6.9 billion in the second quarter, but it's losing market share to a ...

LLY’s slashed revenue and earnings guidance for 2024 were a surprise, especially given substantial raises to its outlook ...

OZEMPIC and other “weight loss” jabs have now been linked to ten deaths in the UK. There have also been 7,228 reports of ...